Fortress Biotech, Inc.
FBIOP
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dā¦ read more
Healthcare
Biotechnology
7 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$6.78
Price-0.80%
-$0.05
1Y
Price
Market Cap
$53.335m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-51.3%
EBITDA Margin+94.4%
Net Profit Margin-167.9%
Free Cash Flow MarginRevenue
$59.301m
+2.8%
1y CAGR-5.8%
3y CAGR-1.8%
5y CAGREarnings
-$14.730m
+68.0%
1y CAGR+40.7%
3y CAGR+22.1%
5y CAGREPS
-$1.16
+56.9%
1y CAGR+55.6%
3y CAGR+36.0%
5y CAGRBook Value
$37.383m
$159.895m
Assets$122.512m
Liabilities$69.219m
DebtDebt to Assets
43.3%
-1x
Debt to EBITDAFree Cash Flow
-$80.089m
+15.9%
1y CAGR+23.8%
3y CAGR+8.5%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company